UAE – DIHAD Sustainable Humanitarian Foundation has entered into a deal with the UAE-based healthcare group Axios International for a partnership with its ‘ForeverCare’ initiative to promote philanthropy and humanitarian work.
The ForeverCare Initiative, which collects medicines and medical supplies from companies and pharmaceutical manufacturers to provide them to countries in need, was launched during the 18th edition of the Dubai International Humanitarian Aid & Development Conference & Exhibition (DIHAD).
The initiative also helps to further cultivate the UAE’s imprint in all humanitarian fields and enhance the aspects of interdependency and cohesion in the international community.
The landmark agreement lands in connection with the UAE’s approach for humanitarian efforts that aims in providing treatment to patients in need via sustainable solutions and ensure stability of charitable work in the medical field.
The agreement stipulates that the cooperation with Axios International is intended to exchange expertise in the humanitarian field between the two parties and to spread awareness regarding the importance of providing medicine to countries in need.
It is also designed to provide medicines, medical supplies, and humanitarian aid through its network of specialists in the field.
This agreement will also help identify the challenges facing the medical and pharmaceutical sectors in general, and work to find appropriate solutions and advanced mechanisms of action in accordance with global standards.
Improving access to healthcare
Ambassador Dr. Abdul Salam Al Madani, Roving ambassador for the parliamentary assembly of the Mediterranean for the GCC and chairman of DIHAD Sustainable Humanitarian Foundation, said the aim of the partnership was to improve access to innovative treatment and medicines for low-income communities around the world, especially for those who cannot afford treatment for their illness.
This agreement will also help identify the challenges facing the medical and pharmaceutical sectors in general, and work to find appropriate solutions and advanced mechanisms of action in accordance with global standards.
The ForeverCare Initiative aims to improve access to innovative treatment and medicines for low-income communities around the world, especially for those who cannot afford treatment for their illness.
The partnership is also envisioned to help identify the challenges facing the medical and pharmaceutical sectors in general, and work to find appropriate solutions and advanced mechanisms of action in accordance with global standards.
This will help to provide wider access to innovative medication for those who are affected, and ultimately giving them greater hope for a better life.
Anas Nawfal Al Saffarini, Senior Director, Greater Mena at Axios International, said: “This reflects the Axios commitment to meeting the needs of patients around the world with efficient speed and the highest quality standards.
“We believe in the importance of joining forces to build distinguished partnerships that benefit everyone.”
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
